Association between hearing sensitivity and dopamine transporter availability in Parkinson's disease
Elena Garasto1, Alessandro Stefani1, Mariangela Pierantozzi1
1Parkinson's Center, Department of Systems Medicine, University of Rome 'Tor Vergata', Rome 00133, Italy.
Brain Communications
|April 3, 2023
Summary
Parkinson's disease patients show impaired hearing linked to dopamine transporter availability, particularly in those with left-sided motor symptoms. This suggests hearing tests could help subtype Parkinson's disease.
Area of Science:
- Neurology
- Audiology
- Nuclear Medicine
Background:
- Previous studies indicated hearing impairment and lateralization in Parkinson's disease (PD) patients.
- Hearing dysfunction in PD was noted to be worse on the side with more severe motor symptoms.
Purpose of the Study:
- To investigate the association between basal ganglia dopamine transporter availability and hearing function in PD patients.
- To examine the lateralization of hearing and dopamine transporter dysfunction relative to motor symptoms.
- To differentiate between left-sided and right-sided predominant motor symptoms in PD patients.
Main Methods:
- Utilized pure tone audiometry and distortion product otoacoustic emissions for audiological testing.
- Assessed dopamine transporter availability using 123I-FP-CIT striatal uptake scans.
- Included 39 right-handed PD patients, categorizing them by predominant motor symptom side.
Main Results:
- A significant association was found in the left-side predominant PD group between otoacoustic emission levels and contralateral dopamine transporter availability.
- In the left-side predominant group, hearing threshold was associated with the difference in dopamine transporter availability between ipsilateral and contralateral sides.
- Hearing impairment lateralization correlated with motor symptom asymmetry exclusively in left-side predominant PD patients.
Conclusions:
- The association between hearing function and dopamine transporter availability supports the role of dopamine depletion in PD-related hearing decline.
- Findings highlight significant differences between PD patients with left-sided versus right-sided predominant motor symptoms.
- Peripheral hearing function evaluation and its lateralization may serve as crucial biomarkers for PD subtyping.
Related Concept Videos
Parkinson's Disease: Treatment
321
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
321
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Overview
632
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
632


